Table 1: Patient backgrounds and status of concomitant drug administration

Sex Male 35 Status of complications
Female 10
mean ± SD
Age(years) 61.1 ± 12.0 Retinopathy 13.3%
Weight(kg) 66.5 ± 12.9 Nephropathy 9.8%
BMI(kg/m2) 24.7 ± 4.0 Neuropathy 26.7%
HbA1c(%) 7.4 ± 1.0 IHD 20.0%
Non-fasting Glu(mg/dL) 164.6 ± 39.2 CI 13.3%
LDL-C(mg/dL) 102.9 ± 19.7 ASO 0.0%
HDL-C(mg/dL) 60.7 ± 19.3 Status of antihypertensive drug administration
Non-fasting TG(mg/dL) 137.4 ± 93.9 ARB 31.1%
SBP(mmHg) 125.2 ± 12.8 CCB 31.1%
DBP(mmHg) 67.6 ± 9.0 Status of anti-dyslipidemiadrug administration
Apo B(mg/dL) 91.0 ± 16.4 Statin 60.0%
Apo A-I(mg/dL) 153.1 ± 27.4 Fibrate 6.6%
Serum CPR(ng/mL) 4.1 ± 2.1 Ezetimibe 8.9%